• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫系统在大鼠粪便微生物群移植诱导的血管功能和血压控制中的作用。

Role of the immune system in vascular function and blood pressure control induced by faecal microbiota transplantation in rats.

机构信息

Department of Pharmacology, School of Pharmacy, University of Granada, Centro de Investigaciones Biomédicas, Granada, Spain.

Instituto de Investigación Biosanitaria de Granada, ibs.GRANADA, Granada, Spain.

出版信息

Acta Physiol (Oxf). 2019 Sep;227(1):e13285. doi: 10.1111/apha.13285. Epub 2019 Jun 2.

DOI:10.1111/apha.13285
PMID:31004464
Abstract

AIM

High blood pressure (BP) is associated with gut microbiota dysbiosis. The aim of this study was to investigate whether changes in gut microbiota induced by exchanging the gut microbiota between spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto (WKY) alter the gut-immune system interaction inducing changes in vascular function and BP.

METHODS

Twenty-week-old recipient WKY and SHR were orally gavaged with donor faecal contents from WKY or SHR. In additional experiments, we used a design to determine whether blockade of B7-dependent costimulation with CTLA4-Ig or blockade of IL-17 with IL-17-neutralizing antibody could prevent hypertension caused by faecal microbiota transplantation (FMT) from SHR to WKY.

RESULTS

Correlation analyses identified the bacterial abundance of Turicibacter and S24-7_g that, respectively, positively and negatively correlated with systolic BP. FMT from WKY rats to SHR rats reduced basal systolic BP, restored the imbalance between Th17/Treg in mesenteric lymph nodes (MLNs) and aorta, and improved endothelial dysfunction and vascular oxidative status found in SHR transplanted with SHR faeces. FMT from SHR to WKY increased CD80 and CD86 mRNA levels and T cells activation in MLNs, circulating T cells, aortic T cell infiltration, impaired endothelial function and increased basal SBP. These effects were abolished by blockade of B7-dependent costimulation with CTLA4-Ig. IL-17a neutralizing antibody reduced SBP and improved endothelial dysfunction induced by FMT from SHR to WKY.

CONCLUSION

Gut microbiota is an important factor involved in the control of BP, as a consequence of its effect in T-cell activation in gut immune system and vascular T-cells accumulation.

摘要

目的

高血压(BP)与肠道微生物失调有关。本研究旨在探讨自发性高血压大鼠(SHR)和正常血压 Wistar-Kyoto(WKY)之间肠道微生物群的变化是否通过交换肠道微生物群而改变肠道-免疫系统相互作用,从而导致血管功能和血压的变化。

方法

20 周龄的受体 WKY 和 SHR 经口给予 WKY 或 SHR 的供体粪便内容物。在额外的实验中,我们使用一种设计来确定 CTLA4-Ig 阻断 B7 依赖性共刺激或 IL-17 中和抗体阻断 IL-17 是否可以防止 SHR 粪便微生物群移植(FMT)引起的 WKY 高血压。

结果

相关分析确定了 Turicibacter 和 S24-7_g 的细菌丰度,它们分别与收缩压呈正相关和负相关。WKY 大鼠到 SHR 大鼠的 FMT 降低了基础收缩压,恢复了肠系膜淋巴结(MLNs)和主动脉中 Th17/Treg 的失衡,并改善了 SHR 接受 SHR 粪便移植时发现的内皮功能障碍和血管氧化状态。SHR 到 WKY 的 FMT 增加了 MLNs 中 CD80 和 CD86 mRNA 水平和 T 细胞活化、循环 T 细胞、主动脉 T 细胞浸润、内皮功能受损和基础 SBP 升高。这些作用被 CTLA4-Ig 阻断 B7 依赖性共刺激所消除。IL-17a 中和抗体降低了 SHR 到 WKY 的 FMT 引起的 SBP 和改善了内皮功能障碍。

结论

肠道微生物群是控制血压的一个重要因素,因为它会影响肠道免疫系统中的 T 细胞活化和血管 T 细胞积聚。

相似文献

1
Role of the immune system in vascular function and blood pressure control induced by faecal microbiota transplantation in rats.免疫系统在大鼠粪便微生物群移植诱导的血管功能和血压控制中的作用。
Acta Physiol (Oxf). 2019 Sep;227(1):e13285. doi: 10.1111/apha.13285. Epub 2019 Jun 2.
2
Differing contributions of the gut microbiota to the blood pressure lowering effects induced by first-line antihypertensive drugs.一线降压药物降压作用中肠道微生物菌群的不同贡献。
Br J Pharmacol. 2024 Sep;181(18):3420-3444. doi: 10.1111/bph.16410. Epub 2024 May 21.
3
Critical Role of the Interaction Gut Microbiota - Sympathetic Nervous System in the Regulation of Blood Pressure.肠道微生物群与交感神经系统的相互作用在血压调节中的关键作用。
Front Physiol. 2019 Mar 8;10:231. doi: 10.3389/fphys.2019.00231. eCollection 2019.
4
Changes to the gut microbiota induced by losartan contributes to its antihypertensive effects.氯沙坦诱导的肠道微生物群变化有助于其降压作用。
Br J Pharmacol. 2020 May;177(9):2006-2023. doi: 10.1111/bph.14965. Epub 2020 Feb 3.
5
Alterations in the gut microbiota can elicit hypertension in rats.肠道微生物群的改变可引发大鼠高血压。
Physiol Genomics. 2017 Feb 1;49(2):96-104. doi: 10.1152/physiolgenomics.00081.2016. Epub 2016 Dec 23.
6
Mineralocorticoid receptor blockade improved gut microbiota dysbiosis by reducing gut sympathetic tone in spontaneously hypertensive rats.盐皮质激素受体阻断通过降低自发性高血压大鼠的肠道交感神经张力改善肠道微生物群失调。
Biomed Pharmacother. 2023 Feb;158:114149. doi: 10.1016/j.biopha.2022.114149. Epub 2022 Dec 23.
7
Mycophenolate mediated remodeling of gut microbiota and improvement of gut-brain axis in spontaneously hypertensive rats.霉酚酸介导的自发性高血压大鼠肠道微生物群重塑和肠道-大脑轴改善。
Biomed Pharmacother. 2021 Mar;135:111189. doi: 10.1016/j.biopha.2020.111189. Epub 2020 Dec 31.
8
Probiotics Prevent Dysbiosis and the Rise in Blood Pressure in Genetic Hypertension: Role of Short-Chain Fatty Acids.益生菌可预防遗传高血压中的肠道菌群失调和血压升高:短链脂肪酸的作用。
Mol Nutr Food Res. 2020 Mar;64(6):e1900616. doi: 10.1002/mnfr.201900616. Epub 2020 Feb 6.
9
Genetically determined hypertensive phenotype affects gut microbiota composition, but not vice versa.遗传决定的高血压表型影响肠道微生物群落组成,但反之则不然。
J Hypertens. 2021 Sep 1;39(9):1790-1799. doi: 10.1097/HJH.0000000000002864.
10
Lactobacillus induced by irbesartan on spontaneously hypertensive rat contribute to its antihypertensive effect.厄贝沙坦诱导的乳酸菌对自发性高血压大鼠的降压作用。
J Hypertens. 2024 Mar 1;42(3):460-470. doi: 10.1097/HJH.0000000000003613. Epub 2023 Nov 16.

引用本文的文献

1
The Immune Regulation of Melanin From Brisson Against Cyclophosphamide-Induced Immunosuppression.来自布里松的黑色素对环磷酰胺诱导的免疫抑制的免疫调节作用
Food Sci Nutr. 2025 May 9;13(5):e70253. doi: 10.1002/fsn3.70253. eCollection 2025 May.
2
ACE inhibitory casein peptide lowers blood pressure and reshapes gut microbiota in a randomized double blind placebo controlled trial.在一项随机双盲安慰剂对照试验中,具有血管紧张素转换酶抑制活性的酪蛋白肽可降低血压并重塑肠道微生物群。
Sci Rep. 2025 Apr 22;15(1):13840. doi: 10.1038/s41598-025-98446-6.
3
Fecal microbiota transplantation for the treatment of intestinal and extra-intestinal diseases: Mechanism basis, clinical application, and potential prospect.
粪便微生物群移植治疗肠道和肠道外疾病:机制基础、临床应用及潜在前景。
Bioeng Transl Med. 2024 Nov 7;10(2):e10728. doi: 10.1002/btm2.10728. eCollection 2025 Mar.
4
Review of mechanisms and frontier applications in IL-17A-induced hypertension.白细胞介素-17A诱导高血压的机制及前沿应用综述
Open Med (Wars). 2025 Feb 27;20(1):20251159. doi: 10.1515/med-2025-1159. eCollection 2025.
5
The Interplay between Cardiovascular Disease, Exercise, and the Gut Microbiome.心血管疾病、运动与肠道微生物群之间的相互作用
Rev Cardiovasc Med. 2022 Oct 27;23(11):365. doi: 10.31083/j.rcm2311365. eCollection 2022 Nov.
6
Combating hypertension beyond genome-wide association studies: Microbiome and artificial intelligence as opportunities for precision medicine.超越全基因组关联研究对抗高血压:微生物组与人工智能作为精准医学的机遇
Camb Prism Precis Med. 2023 May 16;1:e26. doi: 10.1017/pcm.2023.13. eCollection 2023.
7
The role of short-chain fatty acids produced by gut microbiota in the regulation of pre-eclampsia onset.肠道微生物产生的短链脂肪酸在子痫前期发病中的调节作用。
Front Cell Infect Microbiol. 2023 Jul 12;13:1177768. doi: 10.3389/fcimb.2023.1177768. eCollection 2023.
8
Small fish, big discoveries: zebrafish shed light on microbial biomarkers for neuro-immune-cardiovascular health.小鱼,大发现:斑马鱼为神经 - 免疫 - 心血管健康的微生物生物标志物研究带来启示。
Front Physiol. 2023 Jun 1;14:1186645. doi: 10.3389/fphys.2023.1186645. eCollection 2023.
9
Obstructive Sleep Apnea-Induced Hypertension Is Associated With Increased Gut and Neuroinflammation.阻塞性睡眠呼吸暂停相关性高血压与肠道和神经炎症增加有关。
J Am Heart Assoc. 2023 Jun 6;12(11):e029218. doi: 10.1161/JAHA.122.029218. Epub 2023 Jun 1.
10
Gut Microbiota and Cardiovascular Disease: Evidence on the Metabolic and Inflammatory Background of a Complex Relationship.肠道微生物群与心血管疾病:复杂关系的代谢和炎症背景证据。
Int J Mol Sci. 2023 May 22;24(10):9087. doi: 10.3390/ijms24109087.